Insider Trading Activity Insys Therapeutics, Inc. (NASDAQ:INSY) – CEO Bought 5,500 shares of Stock

Insider Trading Activity For Insys Therapeutics, Inc. (NASDAQ:INSY)

Story continues below

Saeed Motahari , CEO of Insys Therapeutics, Inc. (NASDAQ:INSY) reportedly Bought 5,500 shares of the company’s stock at an average price of 8.92 for a total transaction amount of $49,060.00 SEC Form

Insider Trading History For Insys Therapeutics, Inc. (NASDAQ:INSY)

  • On 5/7/2013 Patrick Fourteau, Director, bought 50,000 with an average share price of $8.36 per share and the total transaction amounting to $418,000.00.View SEC Filing
  • On 5/13/2013 Patrick Fourteau, Director, bought 4,800 with an average share price of $10.90 per share and the total transaction amounting to $52,320.00.View SEC Filing
  • On 5/14/2013 Patrick Fourteau, Director, bought 5,000 with an average share price of $10.90 per share and the total transaction amounting to $54,500.00.View SEC Filing
  • On 5/24/2013 Pierre Lapalme, Director, bought 3,000 with an average share price of $10.39 per share and the total transaction amounting to $31,170.00.View SEC Filing
  • On 6/4/2013 Michael L Babich, CEO, bought 1,250 with an average share price of $10.93 per share and the total transaction amounting to $13,662.50.View SEC Filing
  • On 8/14/2013 Patrick Fourteau, Director, bought 5,000 with an average share price of $23.77 per share and the total transaction amounting to $118,850.00.View SEC Filing
  • On 8/16/2013 Michael Babich, CEO, bought 1,000 with an average share price of $24.90 per share and the total transaction amounting to $24,900.00.View SEC Filing
  • Analyst Ratings For Insys Therapeutics, Inc. (NASDAQ:INSY)
    These are 2 Hold Ratings, 2 Buy Ratings .
    The current consensus rating for Insys Therapeutics, Inc. (NASDAQ:INSY) is Buy (Score: 2.50) with a consensus target price of $12.67 , a potential (39.81% upside)

    Analyst Ratings History For Insys Therapeutics, Inc. (NASDAQ:INSY)

    • On 3/9/2016 JMP Securities Lower Price Target of rating Market Outperform with a price target of $38.00 to $30.00
    • On 4/14/2016 Janney Montgomery Scott Initiated Coverage of rating Buy with a price target of $22.00
    • On 6/9/2017 Jefferies Group LLC Reiterated Rating Buy with a price target of $14.00
    • On 7/26/2017 Piper Jaffray Companies Set Price Target of rating Hold with a price target of $10.00
    • On 8/3/2017 Oppenheimer Holdings, Inc. Reiterated Rating Hold
    • On 8/4/2017 Royal Bank Of Canada Lower Price Target of rating Outperform to Outperform with a price target of $16.00 to $14.00

    Recent Trading Activity for Insys Therapeutics, Inc. (NASDAQ:INSY)
    Shares of Insys Therapeutics, Inc. closed the previous trading session at 9.06 down -0.01 -0.11% with 750,235 shares trading hands.

    An ad to help with our costs